PSYCH Symposium: London 2022 Shaping the Future of Psychedelic Healthcare
London, UK | May 11, 2022
PSYCH Symposium is a unique experience that enables industry leaders to connect and collaborate to expedite access to psychedelic healthcare across Europe.
The conference brings together prominent thought-leaders from research, policy and business – including MAPS’ Rick Doblin, Drug Science’s David Nutt and COMPASS Pathways’ George Goldsmith.